Search for: "SANOFI-AVENTIS (FRANCE)"
Results 21 - 40
of 42
Sorted by Relevance
|
Sort by Date
8 Oct 2019, 1:37 am
Francois Pochart and Thierry LautierThe transposition of the “trade secrets” directive in France allowed the introduction of new legal tools that apply to ex parte investigation measures and infringement seizures (“saisie-contrefaçon”). [read post]
24 Aug 2011, 6:26 am
Cambridge was praised for the strong network of bicycle lanes and shared lane space along the Massachusetts institute of Technology (MIT) campus and nearby technology companies, such as Genzyme, Sanofi Aventies, Biogen Idec and Akamai. [read post]
10 Aug 2011, 4:30 am
”: a note on Neurim (The SPC blog) France: The end of the reform on the appearance of generic drugs and IPR (Class 46) Spain: A SHED OF LIGHT IN THE DARK: First Spanish decision admitting post-grant claim limitations under article 138.3 of CPE 2000: Sanofi-Aventis v. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
2 Oct 2012, 5:57 am
Sur le plan économique, avec des exportations vers la France de 49,3 M€ et des importations de France de 1 155,4 M€, le Panama est parmi les pays d’Amérique latine, le 3ème pays client de la France et son 16ème pays fournisseur. [read post]
16 Mar 2011, 3:50 am
Abbott: Federal Circuit struggles to articulate a coherent standard for compliance with the Lilly written description requirement (Holman’s Biotech IP Blog) Lexapro (Escitalopram) – US: CAFC affirms obviousness of Infosint’s patent claims (IPBiz) Lotronex (Alosetron) – US: Prometheus files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Pravastatine – Belgium/France: Post-expiry saisie-contrefaçon: Belgium and… [read post]
31 Dec 2020, 11:41 pm
The French government wanted to avoid two things:They didn't want Sanofi-Aventis to lose market share, as a result of its failure to provide a competitive COVID-19 vaccine, to German and American companies.They also wanted to avoid a situation in which a German company (founded and led by Turkish immigrants) would have "saved" Europe from COVID-19.So Muckron, probably through French EU fake news commissioner Thierry Breton, practically vetoed any commitment to other… [read post]
27 Feb 2009, 12:24 pm
En termes de déposants, Philips est toujours en tête, devant Samsung, Siemens, BASF, Matsushita et Robert Bosch.Le premier déposant français pointe à la 36ème place (Thomson Licensing), suivi du CEA (53ème), de L'Oreal (54ème), PSA (60ème), France Telecom… [read post]
25 Jan 2009, 2:36 pm
The last big pharmaceutical industry acquisition came in August 2004, when Paris-based Sanofi-Synthelabo acquired Aventis SA of Strasburg, France, for $64.4 billion to create Sanofi Aventis SA, France's largest drugmaker. [read post]
3 Aug 2011, 3:31 am
Application fee increases by a whopping 19.4% (or almost $300K) (FDA Law Blog) US: Life sciences venture funding up 37% in second quarter (Patent Docs) Products Arava (Leflunomide) – Australia: FCA ‘evergreens’ Arava: Sanofi-Aventis Australia v Apotex (Patentology) Cambia (Diclofenac) – US: Nautilus files patent infringement complaint against Edict Pharmaceuticals in response to Para IV certification filing (Patent Docs) Cenestin – US: CAFC… [read post]
29 Dec 2010, 2:57 am
(Spicy IP) Fentanyl – Germany: Supreme Court overrules Federal Patent Court’s restrictive interpretation in case of inconsistency between preamble and claim (EPLAW) Fluvastatine – Belgium: Court of Appeal Brussels preliminarily enjoins Mylan from infringing Novartis’ patent (Kluwer Patent Blog) Glucotrol (Glipizide) – US: Alza files patent infringement complaint against Mylan following Para IV certification filing (Patent Docs) Hectorol (Doxercalciferol) – US:… [read post]
13 Jun 2008, 3:40 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
26 Apr 2015, 4:30 am
Music and movie firms back website-blocking in Singapore http://t.co/VyYvVZsIN0 -> Goebbels' estate sues Random House for diary royalties http://t.co/1PDCxZpeuA -> Companies' 'fears are real' with Chinese cyber law http://t.co/4DwKwMLVEx -> European privacy watchdogs join forces to probe Facebook – Oneindia http://t.co/e6M4Q2OEcC -> Computer and Internet Law Weekly Updates for 2015-04-18: blogged: Computer and Internet Law Weekly Updates for…… [read post]
16 Jan 2009, 7:00 am
(IPKat) Benoit Battistelli, director general of France’s INPI, appointed as next chair of EPO Administrative Council (Managing Intellectual Property) European patent trolls feel the heat: Nokia reports IP.com to the European Commission (IAM) Agricultural product quality: MARQUES speaks out (Class 46) European Patent Office to replace corrupt US assignment data (Daily Dose of IP) Finland Helsinki Court of Appeal denies Akun Tehdas Oy’s appeal and maintains… [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
9 Aug 2008, 1:50 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
15 Mar 2007, 2:12 am
Other pharmaceutical companies that have filed WIPO cases in the past include Pharmacia & Upjohn (in relation to Rogaine), American Home Products, McNeil Consumer Brands (Tylenol), Pfizer (Viagra), Merck, Sanofi-Aventis (Ambien), CVS Pharmacy, Lilly ICOS, Valeant, and Bayer. [read post]
2 Aug 2008, 12:54 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
